Ala. Admin. Code r. 610-X-13-.04 - Board Recognized Substance Use Disorder Treatment Providers

Current through Register Vol. 40, No. 6, March 31, 2022

(1) It is within the Board's discretion to recognize treatment providers for substance use disorders.
(2) The Board-recognized substance use disorder treatment provider shall meet the following criteria:
(a) Conduct or provide for, by a qualified provider, assessment, evaluation, diagnosis, and treatment of substance abuse or dependence, utilizing DSM-IV-TR or DSM-V criteria by a qualified provider that includes mental disorder diagnoses; factors including psychosocial, contextual and environmental factors: level of functioning; and disability.
(b) Issue treatment recommendations based on ASAM Criteria.
(c) Conduct, during the initial phase of treatment, biological testing and screening for drugs, chemicals, and alcohol that are analyzed by qualified medical and laboratory personnel. A drug screen that is positive during treatment requires confirmation, at the applicant or licensed nurse's expense, from a laboratory approved by the Board. The treatment provider shall notify the Board's designee(s) of any drug screen deemed positive.
(d) Communicate, in a timely manner, with authorized Board designee(s), through electronic communications and written reports:
1. Compliance or noncompliance with treatment requirements.
2. Data necessary to determine applicability of terms and conditions of and compliance with the VDAP Agreement, including, but not limited to, all information required in this section, as well as reports regarding attendance at treatment and aftercare/continuing care and results of any biological testing or screening for drugs, chemicals, and alcohol.
3. Changes in treatment plan based on the progress of the licensed nurse or applicant.
(e) Provide individualized written plan(s) of care including assessment and diagnosis, treatment goals, discharge criteria, guidelines for continuing recovery, and recommendations for return to nursing practice.
(f) Certification by the State Department of Mental Health or approved by a Board-recognized approving body.
(g) Conduct or provide for Continuing Care/Aftercare for a minimum one day per week for twelve months or longer if required by the treatment provider following completion of treatment.
(h) Incorporate an abstinence philosophy into treatment and require, at a minimum, the applicant or licensee's attendance at a minimum of three (3) abstinence-oriented support group meetings per week during treatment.
(i) For programs offering only intensive outpatient treatment, provide at a minimum 100 hours of treatment per episode, excluding continuing care, at least three (3) days per week in the initial phase of treatment.
(j) Provide all written records requested by the Board in a timely manner. Failure to respond to requests for written records may result in removal of the Board-recognized treatment provider from the list of Board's resources.

Notes

Ala. Admin. Code r. 610-X-13-.04
New Rule: Filed July 28, 1994; Effective August 29, 1994. Repealed and New Rule: Filed May 20, 2002; effective June 24, 2002. Amended: Filed November 22, 2005; effective December 27, 2005. Amended: Filed August 20, 2010; effective September 24, 2010. Amended by Alabama Administrative Monthly Volume XXXII, Issue No. 11, August 29, 2014, eff. 8/28/2014.

Author: Alabama Board of Nursing

Statutory Authority: Code of Ala. 1975, ยง 34-21-25.

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.